Target Name: MIR574
NCBI ID: G693159
Review Report on MIR574 Target / Biomarker Content of Review Report on MIR574 Target / Biomarker
MIR574
Other Name(s): hsa-miR-574-3p | MicroRNA 574 | hsa-mir-574 | MIR574-3p | mir-574 | microRNA 574 | hsa-miR-574-5p | MIRN574

MIR574: A Potential Drug Target and Biomarker

MIR574 (hsa-miR-574-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and its potential as a drug have sparked a great deal of interest in the scientific community.

MIR574 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in gene expression. It is expressed in a variety of tissues and cells throughout the body and is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

One of the key features of MIR574 is its unique structure. It is a single-stranded RNA molecule that has a length of approximately 200 nucleotides. It has a partial double-stranded structure at its middle, with a unique 5' end that contains a single nucleotide. This 5' end is known as the endogenous signal, and it is thought to play a role in the stability and translation of MIR574.

Another unique feature of MIR574 is its expression patterns. It is expressed in a variety of tissues and cells throughout the body, including the brain, heart, liver, and pancreas. It is also expressed in various cell types, including cancer cells. This makes it an attractive target for researchers to study the effects of drugs on these different cell types and to identify potential drug targets.

In addition to its unique structure and expression patterns, MIR574 has also been shown to play a role in the regulation of cellular processes. Studies have shown that MIR574 is involved in the regulation of cell apoptosis, which is the process by which cells die naturally in response to various stimuli, including those caused by drugs. It is also involved in the regulation of cell proliferation, and has been shown to play a role in the development of cancer.

The potential as a drug target for MIR574 is due to its unique structure and expression patterns, as well as its involvement in cellular processes that are thought to be important in the development and progression of various diseases. Its unique 5' end and its expression in various tissues and cell types make it an attractive target for researchers to study the effects of drugs on these different cell types and to identify potential drug targets.

MIR574 has also been shown to be involved in the regulation of inflammation, which is a critical aspect of the immune system. Studies have shown that MIR574 is involved in the regulation of the production of pro-inflammatory cytokines, which play a role in the development of inflammatory diseases. This makes it an attractive target for drugs that are designed to treat inflammatory diseases.

In conclusion, MIR574 is a unique and attractive target for drug research. Its unique structure and expression patterns, as well as its involvement in cellular processes that are thought to be important in the development and progression of various diseases, make it an attractive candidate for drug development. Further studies are needed to fully understand the potential of MIR574 as a drug target and to identify the best ways to use it for the treatment of various diseases.

Protein Name: MicroRNA 574

The "MIR574 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR574 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615 | MIR616 | MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626 | MIR627 | MIR628 | MIR629 | MIR630 | MIR631 | MIR632 | MIR633 | MIR634 | MIR635 | MIR636 | MIR637 | MIR638 | MIR639 | MIR640